FINWIRES · TerminalLIVE
FINWIRES

Aimia To Renew Its Normal Course Issuer Bid

By

Aimia's (AIM.TO) board authorized the renewal of its Normal Course Issuer Bid (NCIB) to buy back for cancellation up to 10% of its public float of common shares or about 5-million common shares, subject to the approval of the Toronto Stock Exchange (TSX), it said on Thursday.

The bid is expected to be renewed on or about June 6, 2026, and to end on June 5, 2027, at the latest, subject to the approval of the TSX. Aimia also intends to enter into a pre-defined plan with its broker to allow for the buy-back of common shares at times when the company ordinarily would not be active in the market due to its pre-scheduled blackout periods.

As at April 30, the company had 88.8-million issued and outstanding common shares.

Shares of the company closed up 1.1% to $2.7 on Wednesday on the TSX.

Related Articles

Mining & Metals

Aya Gold & Silver's Q1 Net Income Surges 600% YoY on Higher Prices

Aya Gold & Silver's (AYA.TO) net income surged 600% year over year in the first quarter amid higher silver equivalent prices, the company said Thursday.The miner reported a net income of US$49 million, or $0.33 per diluted share, in the three months ended March 31, jumping from $7 million, or $0.05 per diluted share, a year ago.Analysts expected Aya to book earnings of $0.38 per share, according to a consensus estimate compiled by FactSet.Revenue soared 247% year over year to $117 million in the first quarter, driven by a 158% increase in average net realized silver equivalent prices, as well as higher sales.Consolidated silver equivalent production jumped 40% year over year to 1.5 million ounces of silver equivalent."Despite challenging weather conditions we delivered strong production, record mining rates and cash flow, highlighting the strength and resilience of our operations," President and Chief Executive Officer Benoit La Salle said.

$AYA.TO
Mining & Metals

Update: Quebecor Reports Q1 Beat; Amends NCIB; But "Extremely Cautious" On "Crisis" In Media Industry

Canadian telco giant Quebecor (QBR-A.TO, QBR-B.TO) said Thursday it remains "extremely cautious due to the deep, ongoing structural crisis in the media industry" even as it reported a rise in adjusted net income and revenue for the first quarter, beating analysts' expectations on both, while it also amended its normal course issuer bid.For the three months ended March 31, 2026, the company reported adjusted net income of $219.5 million or adjusted net income per basic share of $0.97 compared with $185.1 million or adjusted EPS of $0.80, a year earlier. The result beat a consensus estimate compiled by FactSet of $0.93 EPS.Revenue for the quarter increased to $1.40 billion compared with near $1.34 billion, a year-ago, beating a consensus estimate compiled by FactSet of near $1.37 billion."While we are pleased with these results, we remain extremely cautious due to the deep, ongoing structural crisis in the media industry," said Quebecor Chief Executive Pierre Karl Peladeau. "The dominance of GAFAM over the advertising market, cord-cutting, drastically reduced support from the Canada Media Fund, unfair competition from CBC/Radio-Canada and the heavy regulatory burden imposed by the Canadian Radio-television and Telecommunications Commission continue to weaken private broadcasters.""Facing these persistent challenges, a concerted effort by all stakeholders -- governments, the CRTC, industry associations and unions -- is needed to rebuild a viable model that reflects market realities and preserve our collective ability to produce and deliver news, entertainment and sports content to domestic audiences and support the ecosystem that depends on it," added Peladeau.Its board also declared a quarterly dividend of $0.40 per share on its Class A Shares and Class B Shares, unchanged from the prior quarter, payable on June 23, to shareholders of record at the close of business on May 29.Quebecor is amending its NCIB in order to increase the maximum number of Class B Subordinate Voting Shares (with voting rights) that may be repurchased, from 5 million and representing 3.2% of the issued and outstanding as of August 1st, 2025, to 7 million and representing approximately 4.5%. No other terms of the NCIB have been amended.

$QBR-A.TO$QBR-B.TO
Mining & Metals

BriaCell Therapeutics Completes Manufacturing Bria-PROS+ Clinical Supplies

BriaCell Therapeutics (BCT.TO), down near 1% in U.S. pre-market trade, has completed manufacturing clinical supplies of Bria-PROS+, its next generation, personalized, off-the-shelf, cell-based immunotherapy candidate for prostate cancer, the company said on Thursday.BriaCell was awarded a US$2 million non-dilutive grant from the U.S. National Cancer Institute to support the manufacturing and planned clinical evaluation of Bria-PROS+ last August."The design of Bria-PROS+ is intended to support enhanced immune system activation while maintaining a favorable safety profile. We look forward to advancing Bria-PROS+ into the clinic as we seek to develop new treatment options for prostate cancer patients who do not respond to available therapies," said chief executive William Williams.BriaCell's recent AACR preclinical poster presentation demonstrated Bria-PROS+ activating both adaptive and innate immunity, a statement added. The company believes these preclinical findings support further clinical evaluation as a potential immunotherapy for prostate cancer.BriCell shares were last seen down US$0.04, to US$4.14, on in New York trading.

$BCT.TO